MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jjco/hyy145

Медицинская библиотека · Japanese journal of clinical oncology · 2019

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).

Matsuzuka Takashi, Kiyota Naomi, Mizusawa Junki, Akimoto Tetsuo, Fujii Masato, Hasegawa Yasuhisa, Iwae Shigemichi, Monden Nobuya, Matsuura Kazuto, Onozawa Yusuke, Hayashi Ryuichi, Tahara Makoto, Japan Clinical Oncology Group(JCOG) Head and Neck Cancer Study Group

Клиническое исследование II фазыСтатьяПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the clinical impact of cachexia, defined by the combination of albumin and C-reactive protein levels, in patients with unresectable locally advanced head and neck squamous cell carcinomas who received chemoradiotherapy in a phase II trial of JCOG0706.

METHODS

Forty-five patients received radiation for a total of 70 Gy/35fr concurrently with S-1 and cisplatin. The present analysis was conducted in 44 patients with available data. The association between treatment efficacy and cachexia was investigated. Pretreatment cachexia was defined as a serum albumin level of less than 3.5 mg/dl and C-reactive protein level of more than 0.5 mg/dl.

RESULTS

Among the 44 patients, 5 patients had cachexia. On comparison with the cachexic and non-cachexic patients, the percentage of clinical complete remission (20% vs 72%), time to treatment failure at 3 years, (20% vs 53%) and proportion of treatment completion (20% vs 79%) were statistically worse in the cachexic patients, while overall survival, progression-free survival and local progression-free survival at 3 years tended to be worse in cachexic patients.

CONCLUSIONS

This supplementary analysis from a prospective study suggests that a pretreatment status of cancer cachexia is a prognostic factor for treatment outcomes and compliance in patients with locally advanced head and neck squamous cell carcinomas treated with chemoradiotherapy, and a candidate stratification factor in future prospective trials in this population.

Для цитирования: Matsuzuka Takashi, Kiyota Naomi, Mizusawa Junki, Akimoto Tetsuo, Fujii Masato, Hasegawa Yasuhisa, Iwae Shigemichi, Monden Nobuya, Matsuura Kazuto, Onozawa Yusuke, Hayashi Ryuichi, Tahara Makoto, Japan Clinical Oncology Group(JCOG) Head and Neck Cancer Study Group. Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).. Japanese journal of clinical oncology. 2019. DOI: 10.1093/jjco/hyy145.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.